The major DNA-binding protein, or infected-cell protein 8 (ICP8), of herpes simplex virus is required for viral DNA synthesis and normal regulation of viral gene expression. Previous genetic analysis has indicated that the carboxyl-terminal 28 residues are the only portion of ICP8 capable of acting independently as a nuclear localization signal. In this study, we constructed a mutant virus (nllSV) in which the carboxyl-terminal 28 residues of ICP8 were replaced by the simian virus 40 large-T-antigen nuclear localization signal. The The major DNA-binding protein of herpes simplex virus (HSV), infected-cell polypeptide 8, or ICP8, is one of seven virus-encoded proteins required for replication of the HSV genome (3, 4, 20, 24, 39, 40) . ICP8, a 130-kDa polypeptide, is expressed as a 0i or delayed-early-gene product (20, 24) .
The major DNA-binding protein of herpes simplex virus (HSV), infected-cell polypeptide 8, or ICP8, is one of seven virus-encoded proteins required for replication of the HSV genome (3, 4, 20, 24, 39, 40) . ICP8, a 130-kDa polypeptide, is expressed as a 0i or delayed-early-gene product (20, 24) .
From studies of the phenotypes of virus strains containing temperature-sensitive (4, 39) , nonsense, deletion, or sitespecific mutations (5, 8-10, 12, 23) in the ICP8 gene, ICP8 has been shown to have the ability to (i) bind to DNA in vitro and in vivo (1, 16, 18, 25, 31) , (ii) localize to the cell nucleus (10) , (iii) down-regulate the expression of viral genes from parental genomes (12) , (iv) stimulate late-gene expression from progeny templates (9) , and (v) promote organization of nuclear structures involved in viral and cellular DNA replication proteins (5) .
ICP8 binds preferentially to single-stranded DNA (ssDNA) in vitro (1, 16, 18, 25, 32, 33) , and the interaction of ICP8 with ssDNA is cooperative (18, 22, 31) . On the basis of studies of ICP8 molecules expressed by mutant viruses, of in vitro transcription-translation products of ICP8, and of partial protease digestion of purified ICP8, the ICP8 sequences required for ssDNA-binding activity have been mapped between residues 564 and 849 (8, 19, 38) . Genetic evidence indicates that ICP8 specifies other nuclear functions in addition to DNA binding (8, 9) .
The intranuclear localization of ICP8 to specific structures appears to be required for ICP8 to exert its nuclear functions. In the absence of viral DNA replication, ICP8 localizes to nuclear framework-associated structures called prereplicative sites (5, 26, 27) . These structures have been hypothesized to be the sites of viral and cellular protein complexes poised to initiate viral DNA synthesis. As viral DNA replication occurs, progeny viral DNA-ICP8 complexes and additional viral and cellular proteins migrate to large globular replication compartments (5, 26) . HSV polymerase colocalizes with ICP8 in both replicative sites and replication compartments. However, localization of HSV polymerase to these structures is dependent on functional ICP8 molecules. Therefore, ICP8 is required for the assembly of prereplicative sites (5) .
Genetic analysis of ICP8 gene mutants and ICP8-pyruvate kinase fusion proteins demonstrated that the carboxyl-terminal 28 residues of ICP8 constitute the only portion of ICP8 that can function alone as a nuclear localization signal (NLS) (10) . The carboxyl-terminal 28 residues of ICP8 are not needed for ssDNA-binding activity (10) .
To study the functional domains of ICP8 further, we have constructed a mutant virus (nllSV) in which the carboxylterminal 28 residues of ICP8 were replaced by the nuclear localization signal of simian virus 40 (SV40) T antigen. Despite the fact that nllSV was unable to promote viral DNA synthesis, nllSV ICP8 still retains some physical and functional properties of wild-type (wt) ICP8. This paper reports that the carboxyl-terminal 28 residues of ICP8 are required for a function(s) involved in viral DNA replication and that the function(s) missing in nllSV can be supplied in trans by another mutant ICP8 molecule.
MATERUILS AND METHODS
Cells and viruses. Vero cells were grown and maintained as described previously (14) . The growth medium for the neomycin-resistant S-2 cell line included 200 ,ug of the antibiotic G418 per ml during the first passage of the cells after thawing or 500 ,ug of G418 per ml of medium every five passages. TL4 and TL5 cell lines were isolated by procedures described previously (6, 8) . Vero cells were transformed with the plasmid TL4 or TL5 and pSVneo ( Fig. 1) in the presence of the antibiotic G418 (36) . Drug-resistant colonies were isolated, grown into cultures, and screened by indirect immunofluorescence (27) with anti-ICP8 monoclonal antibody lOE-3 (30) for the ability to express mutant forms of ICP8 upon infection by nlO mutant virus. The lOE-3 antibody recognizes TL4 ICP8 and TL5 ICP8 but not nlO ICP8 (10) .
HSV type 1 wt strain KOS1.1 was propagated and assayed as described previously (16, 17) . Mutant viruses were grown in ICP8-expressing S-2 cells (8) .
Plasmids. Plasmids p8B-S, pICP8, pSV8, pSV8.2, and pSVdlOl as well as the nucleotide-numbering system for the ICP8 gene were described previously (7) (8) (9) . The plasmid p8B-S contains the ICP8 gene, including its own promoter. The plasmid pICP8 contains the ICP8 gene coding sequences without its promoter. The plasmid pn9 was generated by linearization of the plasmid pICP8 (which was achieved by partial digestion with SmaI) and subsequent insertion of a 14- 
The underlined amino acid sequences represent the SV40 NLS (13) .
Isolation ofnll and nllSV mutant viruses. The strategy for isolation of nll and nllSV mutant viruses was as described previously (8) . The HD-2 mutant virus contains an in-frame insertion of the lacZ gene in the ICP8 coding sequence and forms blue plaques in the presence of 5-bromo-4-chloro-3-indolyl-p-D-galactopyranoside (X-Gal). This virus served as a recipient in marker transfer experiments to introduce the n9, nll, and nllSV mutations in the ICP8 gene into the viral genome.
Indirect immunofluorescence. Indirect immunofluorescence was performed as described previously (27) (17) . After electrophoresis, the gels were fixed, dried, and exposed to Kodak SB5 film.
Analysis of viral DNA amplification during the course of infection was performed as described previously (9, 29) . The probe used was the plasmid pBR3441 (21) . ssDNA cellulose chromatography. ssDNA cellulose chromatography of infected-cell extracts was performed as described elsewhere (8, 14) .
RESULTS
Phenotype of mutant viruses nll and nIlSV. Our previous genetic analysis demonstrated that the mutant nlO ICP8, which lacks the carboxyl-terminal 36 residues and localizes to the cytoplasm, does not support viral growth in Vero cells even though it binds ssDNA in vitro as tightly as wt ICP8 does (8) . Further study indicated that the carboxylterminal 28 residues are the only portion of ICP8 capable of acting independently as an NLS (10) . Thus, the failure of mutant nlO ICP8 to support viral DNA synthesis may have been solely a consequence of its inability to localize to the cell nucleus. If this were the case, replacement of ICP8 NLS with another known NLS should restore the full functionality of ICP8. Therefore, we constructed two ICP8 mutant viruses. One, nll, lacks the carboxyl-terminal 28 residues of ICP8, and the other (nllSV) has the SV40 T-antigen NLS (NH2-Pro-Lys-Lys-Lys-Arg-Lys-Val-COOH) replacing the carboxyl-terminal 28 residues of ICP8 ( Fig. 1 ).
(i) Subcellular locations of nll ICP8 and nl1SV ICP8. We first used immunofluorescence microscopy to examine the intracellular localization of the nll and nllSV ICP8 polypeptides when they were expressed from plasmids in transfected Vero cells. The nil ICP8 polypeptide remained within the cytoplasm, while the nllSV ICP8 polypeptide localized in the nucleus (11) . We next determined the intracellular distribution of mutant ICP8 molecules when they were expressed from recombinant viruses (Fig. 2) . At 5 hpi, infected Vero cells were fixed and processed for immunofluorescence. Cells infected with wt virus showed that ICP8 localized in the nucleus in characteristic replication compartments in the absence of phosphonoacetic acid (PAA) ( Fig.  2A ) and at prereplicative sites in the presence of PAA (Fig. 2B; 26, 27) . As expected, nll ICP8 localized in the cytoplasm ( Fig. 2C ) because of lack of the carboxyl-terminal 28 residues. In most cells, the nllSV ICP8 localized throughout the cell nucleus ( Fig. 2D ) and did not appear to localize specifically either in replication compartments or at prereplicative sites. Therefore, replacement of the ICP8 NLS with the SV40 T-antigen NLS restored the capacity of mutant ICP8 to localize into the nucleus but not to the same sites as wt ICP8.
(ii) Growth properties of nll and nllSV. Plaque assays were performed to determine whether the mutant viruses were able to grow in Vero cells. Both mutant viruses failed to grow in Vero cells but grew to titers near those of wt on the ICP8-expressing S-2 cell line (Table 1) . Thus, although replacement of the ICP8 NLS with the SV40 T-antigen NLS restored the ability of ICP8 to localize to the nucleus, the substitution did not restore complete functionality of ICP8.
(iii) Marker rescue of mutant viruses nll and nllSV. To verify that the phenotypes of mutant viruses nll and nllSV were due to mutations in the ICP8 gene, we performed marker rescue experiments (Fig. 3) . Homologous recombination between nll DNA or nllSV DNA and a fragment containing a wt ICP8 DNA sequence (p8S/3583) resulted in viral progeny possessing the ability to grow in Vero cells, thereby rescuing the growth deficiencies of nll and nllSV.
J. VIROL. (Fig. 4, lane 12) . Thus Table 3 were assayed for wt recombinants by assaying for the ability to form plaques on Vero cells. ND = titer of <10 PFU/ml. complementation occurred). Thus, the enhancement of growth of mutant virus nllSV by TMA or TL5 was not due to recombination. We conclude that the function(s) required for the mutant virus nllSV DNA replication could be supplied in trans by partially functional TL4 or TL5 ICP8.
(ii) Phenotype of TL4 and TL5 mutants. To study the mechanism of intragenic complementation by ICP8 mutants, we examined the properties of the TML and TL5 ICP8 molecules. Our results indicated that both TLM and TL5 mutant gene products exhibited a trans-dominant phenotype which prevented the introduction of these mutations into virus. We therefore isolated two cell lines, named TL4.6 and TL5.2, which expressed TL4 ICP8 and TL5 ICP8, respectively, upon HSV infection (11) .
Mutant ICP4 molecules containing alterations in the transactivation domain can form a heterodimer with another mutant ICP4 molecule containing an alteration in the DNAbinding domain and can complement each other in trans (34, 35) . To test whether this interpretation could apply to the mutant ICP8 also, we examined the DNA-binding ability of TL4 ICP8 expressed from the cell line. We concluded that TL4 ICP8, like nllSV ICP8, binds ssDNA in vitro as tightly as wt ICP8 does (11) . These results suggested that the mechanism of intragenic complementation between nllSV and TMA ICP8 mutants is different from that of the ICP4 mutants, because both mutant ICP8 molecules can bind DNA. (iii) Formation of replication compartments in nllSV-infected TLA and TL5 cells. Because the plasmid TI4 resulted in more-significant complementation of the growth of nllSV in Vero cells than TL5 did (Table 3) , we used TIA.6 cells for most of our further studies. To examine the localization properties of TL4 ICP8, we infected Vero and TILA.6 cells with n9, nllSV, or wt KOS1.1 for 5 h and then processed the cells for immunofluorescence by using monoclonal antibody 10E-3 as the primary antibody (Fig. 5) . This antibody recognizes the carboxyl-terminal 28 residues of ICP8 (10) and therefore recognizes only the ICP8 expressed from TIA.6 cells ( Fig. 5B and D) and not that expressed by n9 (Fig. 5A) or nllSV (Fig. SC) . The antibody, of course, also recognizes wt ICP8. KOS1.1-infected Vero cells were used for controls of the antibody and formation of replication compartments. Replication compartments were observed in nllSV-infected (Fig. SD) but not n9-infected (Fig. SB) TIA.6 cells. Thus, we conclude that TLA ICP8 could localize into replication compartments in the presence of nllSV ICP8.
(iv) DNA replication in nllSV-infected TL4.6 cells. To determine whether the mutant virus nllSV replicates its DNA in TL4.6 cells, we examined viral DNA accumulation in these cells. Total viral DNA was isolated from mock-, wt-virus-, d301-, or nllSV-infected Vero cells, wt-ICP8-expressing S-2 cell line, and TIA.6 cells at 1 or 16 hpi.
wt-virus-infected Vero cells in the presence or absence of PAA were used as positive and negative controls of viral DNA synthesis, respectively (Fig. 6 ). As expected, mutant d301-infected TL4.6 cells, like d301-infected Vero cells, showed no amplification of viral DNA during the course of infection, indicating that the TL4 ICP8 was unable to promote synthesis of mutant viral DNA. In contrast, n11SV- Vero, wt-ICP8-expressing S-2, and TLA.6 cells were infected with KOS1.1, d301, or nllSV. Total cellular DNA was prepared immediately after viral absorption (1 h) or near the end of the infection cycle (16 h). Equal amounts of each DNA were subjected to fivefold serial dilutions, and the DNAs were bound to a nitrocellulose filter, which was probed with 32P-labeled DNA specific for the VP16 gene. An autoradiograph of the blot is shown.
infected TL4 cells showed substantial amplification of viral DNA during the infection. To quantitate these results, the amount of radioactive probe hybridized to each slot was measured, and the relative amounts of replicated HSV type 1 DNA in each sample were determined. In this particular experiment, the amount of nllSV viral DNA synthesized in TL4 cells was about 42% of the level of DNA synthesized in wt virus-infected Vero cells. We conclude that the function(s) which is required for nllSV to replicate its DNA can be supplied in trans by the mutant TIA ICP8.
(v) Viral gene expression in nllSV-infected TILA cells. ICP8 is not only required for viral DNA replication but is also involved in stimulation of late-gene expression (9) . We therefore examined viral late-gene expression in n11SV-infected TL4.6 cells. Vero cells, wt-ICP8-expressing S-2 cells, and TL4.6 cells were infected with KOS, d301, or nllSV and labeled with [35S]methionine from 9.5 to 10 hpi, and labeled proteins were analyzed by SDS-PAGE (Fig. 7) . Vero cells infected with wt virus in the presence or absence of PAA were used as positive and negative controls for the expression of -y2 genes. When examined in Vero cells, the nllSV mutation resulted in a phenotype similar to that of the negative control with respect to late-gene expression. Detectable levels of y2 viral polypeptides (such as ICP1-2 and ICP15) were not expressed. Similar results were observed in d301-infected Vero cells. These results demonstrated that both nllSV ICP8 and TM4 ICP8 are unable to exert wt ICP8 functions for expression of late genes. However, the defects for mutant nllSV viral late-protein synthesis were corrected by expression of the TL4 ICP8 in TL4.6 cells. The pattern of viral polypeptides synthesized in nllSV-infected TL4.6 cells was indistinguishable from that observed in nllSV-infected wt-ICP8-expressing S-2 cells or in wt-infected Vero cells (Fig. 6 ).
To The functions defective in nllSV ICP8 may be carried out by the carboxyl terminus of ICP8 or other parts of the molecule; however, extensive conformational changes are not apparent in nllSV ICP8, because it still reacts with anti-ICP8 monoclonal antibody 39S, which is very sensitive to conformational changes in ICP8 (7) .
Because monoclonal antibody lOE-3 detects TM4 and TL5 ICP8 but not nllSV mutant ICP8, we do not know whether nllSV ICP8 localized alone or formed a complex with TML or TL5 ICP8 in the nucleus. However, both TML ICP8 and TL5 ICP8 localized to replication compartments after superinfection with the mutant virus nllSV but not after infection with n9, suggesting that these ICP8 molecules can localize to these sites only in the presence of nllSV ICP8. Moreover, because the monoclonal antibody recognized both wt and TM4 ICP8, we know that both ICP8 molecules localized into replication compartments after TL4.6 cells were infected with wt virus. These results suggest that nllSV ICP8 may also localize to replication compartments. Because the alteration in TML or TL5 ICP8, as in nllSV ICP8, is outside of the region required for ssDNA-binding, both mutant ICP8 molecules, as expected, bind to DNA. It is conceivable that the complementing polypeptides of TIA or TL5 ICP8 and nllSV ICP8 do not interact with each other directly but that both bind DNA and that each molecule contributes some activities from different domains to achieve wt ICP8 functions.
An alternative mechanism for intragenic complementation is the formation of a dimer or multimers of nllSV ICP8 and TL4 or TL5 ICP8. It has been reported that ICP8 sediments in a glycerol gradient as a monomer (22) , but the cooperative nature of the binding of ICP8 to ssDNA suggests that ICP8 may form polymers along ssDNA (22) . In multimeric forms, the monomers may be weakly associated and assemble only upon interaction with DNA. Therefore, if multimerization is involved in the intragenic complementation of nllSV ICP8 and TL4 or TL5 ICP8, several models can be considered. First, the fact that nllSV ICP8 did not localize to prereplicative sites or replication compartments may indicate that the SV40 T-antigen NLS did not allow proper targeting of ICP8 to specific sites within the nucleus, where viral DNA replication is initiated. This suggests that the carboxy!-terminal 28 residues of ICP8 may also be involved in determining intranuclear localization and may interact with a component of the cell nucleus to initiate viral DNA replication. Therefore, it is possible that the nllSV ICP8 needs TML or TL5 ICP8 to form the multimers for targeting to replication machinery.
Second, we (8) and others (19) noted that the aminoterminal portion of ICP8 also contributes to the DNAbinding activity of the intact protein, although the DNAbinding region has been identified at the carboxyl-terminal half of ICP8 molecule (8, 19, 38) . This contribution could be due to the intra-or intermolecular interactions of ICP8.
Intermolecular interactions of this type could explain intragenic complementation. A second model is that TL4 or TL5 ICP8 and nllSV ICP8 bind DNA but that they can bind DNA cooperatively only when they interact with each other. If this is true, the domain which is required for formation of polymers must be disturbed in at least one mutant ICP8 molecule and the TIA or TL5 ICP8 can form a heterodimer with nllSV ICP8 but cannot form polymers. This may explain why the efficiency of intragenic complementation of TL4 and nllSV ICP8 reached only 7 
